Mifepristone is the first (and extremely safe) in two medications that people will take during a medication abortion—and access to it is under blatant attack in the courts. Dr. Ushma Upadhyay, Public Health Scientist based at University of California San Francisco, and Julia Kaye, Senior Staff Attorney with the ACLU’s Reproductive Freedom Project, sit down to talk with us about recent anti-abortion propaganda and how it could be used to shape the FDA’s regulations of medication abortion.

A past case, Alliance for Hippocratic Medicine v. FDA, was brought by anti-abortion groups to a federal judge in Texas known to have a hostile record against abortion with the goal of challenging the FDA’s mifepristone regulations. The Supreme Court ruled that these groups could not challenge the regulations in June 2024. Anti-abortion Attorneys General of Missouri, Kansas, and Idaho are now attempting to revive this litigation, called Missouri v. FDA. Meanwhile, a new report from a Project 2025-backed organization falsely states that 11% of people who have a medication abortion have a serious adverse event. Sec. Kennedy has cited this report as a basis for conducting a “complete review” of the FDA’s mifepristone regulations. 

For more information, check out: https://www.cbc.ca/listen/cbc-podcasts/2058-two-blocks-from-the-white-house

Support the show

Follow Us on Social:
Twitter: @rePROsFightBack
Instagram: @reprosfb
Facebook: rePROs Fight Back
Bluesky: @reprosfightback.bsky.social

Buy rePROs Merch: Bonfire store

Email us: [email protected]
Rate and Review on Apple Podcast

Thanks for listening & keep fighting back!